Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Multiple Myeloma and CTLA4[original query] |
|---|
| CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens. Annals of hematology 2018 Mar 97 (3): 485-495. Qin Xiao-Ying, Lu Jin, Li Guo-Xuan, Wen Lei, Liu Yang, Xu Lan-Ping, Chang Ying-Jun, Liu Kai-Yan, Jiang Zheng-Fan, Huang Xiao-J |
| Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers. Frontiers in immunology 2018 9 9 2012. Egg David, Schwab Charlotte, Gabrysch Annemarie, Arkwright Peter D, Cheesman Edmund, Giulino-Roth Lisa, Neth Olaf, Snapper Scott, Okada Satoshi, Moutschen Michel, Delvenne Philippe, Pecher Ann-Christin, Wolff Daniel, Kim Yae-Jean, Seneviratne Suranjith, Kim Kyoung-Mee, Kang Ji-Man, Ojaimi Samar, McLean Catriona, Warnatz Klaus, Seidl Maximilian, Grimbacher Bo |
| PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma. Clinical and experimental medicine 2019 Oct . Kasamatsu Tetsuhiro, Awata Maaya, Ishihara Rei, Murakami Yuki, Gotoh Nanami, Matsumoto Morio, Sawamura Morio, Yokohama Akihiko, Handa Hiroshi, Tsukamoto Norifumi, Saitoh Takayuki, Murakami Hiroka |
- Page last reviewed:Feb 1, 2024
- Content source: